Dataset for complete sputum smear monitoring among adults with pulmonary tuberculosis in central Uganda: evidence from a retrospective cohort study

People with bacteriologically confirmed pulmonary tuberculosis (TB)
require sputum smear monitoring at 2, 5, and 6 months to establish
treatment outcomes. We retrospectively reviewed and abstracted data for
416 persons with bacteriologically confirmed pulmonary TB initiated on
treatment between January 2017 and December 2019 across 11 large TB units
in Masaka district in central Uganda. The dataset includes variables on
health facility attributes and clinical factors. We defined complete
sputum smear monitoring was measured as the receipt of three sputum smear
microscopy tests at 2, 5, and 6 months of TB treatment.